Gregory R. Kardos
- Co-authors
- Gavin P. RobertsonH. DiddensRupert HandgretingerVolker GekelerAstrid KimmigManfred NeumannD. NiethammerRaghavendra Gowda
- Topics
- Melanoma and MAPK Pathways (5 papers)Ubiquitin and proteasome pathways (3 papers)Cancer Research and Treatments (2 papers)
- Cited by
- ToxicologyOncologyCancer Research
- Partner nations
- United StatesHungaryGermany
In The Last Decade
Gregory R. Kardos
9 papers receiving 351 citations
Peers
Comparison fields: 5 of 59
- Molecular Biology 217
- Oncology 134
- Cancer Research 57
- Organic Chemistry 41
- Immunology 32
Countries citing papers authored by Gregory R. Kardos
This map shows the geographic impact of Gregory R. Kardos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory R. Kardos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory R. Kardos more than expected).
Fields of papers citing papers by Gregory R. Kardos
This network shows the impact of papers produced by Gregory R. Kardos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory R. Kardos. The network helps show where Gregory R. Kardos may publish in the future.
Co-authorship network of co-authors of Gregory R. Kardos
This figure shows the co-authorship network connecting the top 25 collaborators of Gregory R. Kardos. A scholar is included among the top collaborators of Gregory R. Kardos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregory R. Kardos. Gregory R. Kardos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 19 | |
| 2 | 18 | |
| 3 | 10 | |
| 4 | 53 | |
| 5 | 43 | |
| 6 | 4 | |
| 7 | 18 | |
| 8 | [Chronic granulomatous disease (CGD): dysfunction of the neutrophil granulocyte NADPH-oxidase enzyme system]. | 1 |
| 9 | Susceptibility of multidrug-resistant human leukemia cell lines to human interleukin 2-activated killer cells. | 187 |
About Gregory R. Kardos
Gregory R. Kardos is a scholar working on Toxicology, Biotechnology and Immunology, having authored 9 papers that have together received 353 indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (5 papers), Ubiquitin and proteasome pathways (3 papers) and Cancer Research and Treatments (2 papers). The work is most often cited by research in Toxicology (30 citations), Oncology (134 citations) and Cancer Research (57 citations). Gregory R. Kardos has collaborated with scholars based in United States, Hungary and Germany. Frequent co-authors include Gavin P. Robertson, H. Diddens, Rupert Handgretinger, Volker Gekeler, Astrid Kimmig, Manfred Neumann, D. Niethammer, Raghavendra Gowda, Hannah C. Wastyk and Arati Sharma. Their work appears in journals such as Cancer Letters, Molecular Cancer Therapeutics and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.